Centiva Capital’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Centiva Capital’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-19,000	Closed	-$189K	–	1752
2021 Q1	$189K	Buy	+19,000	New	+$196K	0.03%	1008

Other funds holding PRDS

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Marathon Asset Management (New York) New York $11.4M AUM 8.79% 1-Year Est. Return